Unlock this StockReport nowClick to Unlock

Verona Pharma Reuters News

VRP 61.5p 4.0  7.0%
3:20pm 1.000k
StockRank



11th Mar PDMR Dealing
7th Mar PDMR Dealing
5th Mar PDMR Dealing
4th Mar BRIEF-Verona Pharma Reports Positive Interim Data With Ensifentrine Dry Powder Inhaler Formulation
4th Mar Verona Pharma Reports Positive Interim Data with Ensifentrine Dry Powder Inhaler Formulation in First of Two-Part Phase 2 Clinical Trial in COPD
4th Mar Verona Pharma Reports Positive Interim Data with Ensifentrine Dry Powder Inhaler Formulation in First of Two-Part Phase 2 Clinical Trial in COPD
28th Feb Verona Pharma to Present at Cowen and Company 39th Annual Health Care Conference
28th Feb Verona Pharma to Present at Cowen and Company 39th Annual Health Care Conference
27th Feb UK Stocks-Factors to watch on Feb. 27
26th Feb BRIEF-Verona Pharma Says FY Reported Operating Loss Of 25.6 Mln Stg
26th Feb Verona Pharma Reports Financial Results for Full Year Ended December 31, 2018 and Provides Clinical Development Update
26th Feb Verona Pharma Reports Financial Results for Full Year Ended December 31, 2018 and Provides Clinical Development Update
20th Feb Verona Pharma to Announce Financial Results for Full Year ended December 31, 2018 and Provide Clinical Development Update
20th Feb Verona Pharma to Announce Financial Results for Full Year ended December 31, 2018 and Provide Clinical Development Update
4th Feb Verona Pharma to Present at Upcoming Investor Conferences
4th Feb Verona Pharma to Present at Upcoming Investor Conferences
14th Jan BUZZ-Verona Pharma: Plunges to record low as lung disease treatment trial fails
14th Jan BRIEF-Verona Pharma Reports Top-Line Data From Three-Day Phase 2 Trial On Nebulized Ensifentrine
14th Jan Verona Pharma Reports Encouraging Top-Line Data from Three-Day Phase 2 Trial Evaluating Nebulized Ensifentrine (RPL554) on Top of Dual Bronchodilator Therapy for COPD Maintenance Treatment
14th Jan Verona Pharma Reports Encouraging Top-Line Data from Three-Day Phase 2 Trial Evaluating Nebulized Ensifentrine (RPL554) on Top of Dual Bronchodilator Therapy for COPD Maintenance Treatment


Let’s get you setup so you get the most out of our service
Done, Let's add some stocks
Brilliant - You've created a folio! Now let's add some stocks to it.

  • Apple (AAPL)

  • Shell (RDSA)

  • Twitter (TWTR)

  • Volkswagon AG (VOK)

  • McDonalds (MCD)

  • Vodafone (VOD)

  • Barratt Homes (BDEV)

  • Microsoft (MSFT)

  • Tesco (TSCO)
Save and show me my analysis